4
Changes in Ownership
ImmunityBio, Inc. Filed Acc 0001326110-26-000084
Director sold 81,056 shares at $10.50 ($851,088)
- Director acquired 55,979 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Cohen Cheryl · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-02 | Exercise or conversion : show line 1 in the form 10b5-1 | +55,979 | $2.98 | $166,817 | 181,365 | D |
| 2026-10-02 | Sale : show line 2 in the form 10b5-1 | −81,056 | $10.50 | $851,088 | 100,309 | D |
| Open-market sales · 81,056 sh · avg $10.50 · $851,088 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-10-02 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) | −55,979 | 55,979 | D |
Loading xslF345X06/wk-form4_1791324339.xml…